Eplerenone relieves spironolactone-induced painful gynaecomastia in patients with decompensated hepatitis B-related cirrhosis.
Mimidis
Konstantinos
K
Papadopoulos
Vassilios
V
Kartalis
Georgios
G
D001201:Ascites / Q000150:complications; D000077545:Eplerenone; D006177:Gynecomastia / Q000139:chemically induced / Q000188:drug therapy*; D019694:Hepatitis B, Chronic / Q000150:complications*; D006801:Humans; D008103:Liver Cirrhosis / Q000821:virology*; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects*; D013148:Spironolactone / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone